Xcout Intel
TransMedics Group, Inc. competitors & alternatives
The 12 closest competitors and alternatives to TransMedics Group, Inc. among medical devices companies — ranked by similarity to what TransMedics Group, Inc. actually does, not by market-cap band.
Subscribe to see TransMedics Group, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
TransMedics Group, Inc. at a glance
TransMedics Group, Inc. is a medical devices company headquartered in Andover, United States. It is publicly listed (TMDX) with a market capitalisation of $2.7B. Xcout tracks 23 named people at TransMedics Group, Inc., including Fernando Araujo (Chief Financial Officer & Treasurer). Xcout recorded 56 job postings from TransMedics Group, Inc. in the last 90 days, naming tools such as Jira, Workday.
TransMedics Group, Inc. leadership
- Fernando AraujoChief Financial Officer & Treasurer
- Gerardo HernandezChief Financial Officer & Treasurer
- Gerardo Hernandez OmanaChief Financial Officer
- Tamer KhayalChief Commercial Officer
- Waleed H. HassaneinFounder, President, Chief Executive Officer & Director
- Waleed HassaneinTransMedics Founder, President and CEO
17 more named people on record for TransMedics Group, Inc., with roles, board committees and tenure — see the full roster →
Hiring at TransMedics Group, Inc.
Xcout recorded 56 job postings from TransMedics Group, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in TransMedics Group, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see TransMedics Group, Inc.'s hiring signals →
Top 12 TransMedics Group, Inc. competitors
Ranked by semantic similarity — how close each company is to TransMedics Group, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Xvivo Perfusion AB (publ) is a specialized medtech company creating advanced technologies for the preservation and perfusion of organs, tissues, and cells, vital for successful transplantation. Founded in 1998 and headquartered in Gothenburg, Sweden, the company extends its operations across Sweden, the United States, the broader regions of North and South America, Europe, the Middle East, Africa, and the Asia Pacific. Their product line encompasses the XVIVO System (XPS), an integrated, off-the-shelf cardiac bypass system engineered for secure normothermic ex vivo lung perfusion (EVLP). Accompanying this is the XPS Disposable Lung Kit, supplying necessary sterile disposables and pre-packaged components. They also provide STEEN Solution, a uniquely formulated buffered extracellular solution optimized for perfusing isolated donor lungs during EVLP, and Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte solution for organ preservation. Additional offerings include the XVIVO Silicone Tubing Set for efficient flushing of donor lungs during procurement, as well as the XVIVO LS and XVIVO Disposable Lung Set, which together constitute a dedicated EVLP device. Furthermore, Xvivo Perfusion supplies the XVIVO Organ Chamber, a single-use sterile disposable container designed as a temporary holding unit for isolated lungs before transplantation, alongside the single-use, sterile XVIVO Lung Cannula Set.
Similar medical devices company
OrganOx is an organ technology company founded as a spin-out from the University of Oxford, United Kingdom. It pioneers liver perfusion technology to address transplant challenges and improve transplant success through innovation and clinical research.
Similar medical devices company
Bridge to Life Ltd. provides organ preservation solutions and proven medical technologies. Headquartered in Duluth, Georgia, the privately held company also maintains European operations.
Biotech
ThermoGenesis Group, Inc. develops and commercializes automated cell processing systems, devices, and CDMO services for the cell and gene therapy industry. The company provides closed-system solutions for clinical biobanking, cellular processing, and manufacturing to support researchers, clinicians, and biomanufacturing organizations.
Similar medical devices company
ALung Technologies, Inc. is a leading provider of low-flow extracorporeal carbon dioxide removal technologies. The company was acquired by LivaNova in May 2022. It focuses on advancing respiratory care solutions.
Similar medical devices company
BioVentrix, Inc. is a privately held specialty medical device company headquartered in Mansfield, Massachusetts. The firm serves cardiothoracic surgeons and patients by developing lifesaving therapies for heart failure.
Medical - Devices
Haemonetics Corporation is a healthcare enterprise dedicated to providing medical products and comprehensive solutions, structured into three main business areas: Plasma, Blood Center, and Hospital. In its Plasma segment, the company develops automated plasma collection systems, exemplified by the NexSys PCS and PCS2 devices, along with necessary disposables and intravenous solutions. It also offers integrated information technology platforms and the NexLynk DMS donor management system to help plasma customers efficiently manage their donors, operations, and supply chains. The Blood Center division provides advanced automated blood component and manual whole blood collection technologies. This includes MCS brand apheresis equipment for selectively collecting blood components, as well as disposable kits for whole blood collection and storage. Its software offerings feature the SafeTrace Tx blood bank information system and BloodTrack, a sophisticated suite of blood management software and hardware designed to enhance hospital blood bank functionalities and facilitate bedside transfusions. For the Hospital sector, Haemonetics offers hemostasis analyzer systems like TEG, ClotPro, and HAS, which deliver crucial assessments of a patient's overall clotting ability. The TEG Manager software links these analyzers throughout a facility, enabling clinicians to remotely access active and past test results to inform treatment decisions. Additionally, the Cell Saver Elite+ system supports autologous blood recovery across a wide range of surgical procedures, including cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological operations. The company distributes its products and solutions through its own direct sales teams, independent distributors, and sales representatives. Haemonetics Corporation was established in 1971 and is based in Boston, Massachusetts.
Medical Device
ALung Technologies develops extracorporeal respiratory support devices, including the Hemolung Respiratory Assist System, designed to remove carbon dioxide from blood and support patients with acute respiratory failure. Its products are intended for hospitals and critical-care clinicians treating patients who need respiratory support, including certain patients with severe COPD or who may otherwise require mechanical ventilation.
Similar medical devices company
VQ Biomedical develops a minimally-invasive intravascular oxygenation catheter designed to deliver supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure. The technology provides gas exchange independently of injured lungs to support healing while avoiding the complications of mechanical ventilation or external ECMO pumps. The company serves healthcare providers and critical care patients.
Similar medical devices company
Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
Medical - Devices
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Similar medical devices company
BiVACOR, Inc. is a clinical-stage medical device company founded in 2008 that pioneers the development of a total artificial heart to replace failing hearts and restore patient lives. The company is headquartered in Huntington Beach, California, with clinical offices in Houston, Texas, and international facilities in Australia.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of TransMedics Group, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for TransMedics Group, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →